Ovarian Cancer

1. Front Matter

   Pages I-XII

   PDF

2. General Classification of Ovarian Tumours

   • L. Santesson, H. L. Kottmeier

   Pages 1-8

3. Malignant Ovarian Tumours of Mullerian Origin: Some Aspects

   • Antonio Luisi

   Pages 9-22

4. Endometrioid Tumours of the Ovary

   • G. Gricouroff

   Pages 23-39

5. Sex Cord-Mesenchyme Tumours

   • Robert E. Scully

   Pages 40-57

6. Tumours of Germinal Origin

   • Gunnar Teilum

   Pages 58-73

7. Lipoidic Cell Tumors of the Ovary

   • G. Gricouroff, F. Veith

   Pages 74-86

8. Metastatic Ovarian Tumours

   • Antonio Luisi

   Pages 87-104

9. Ovarian Cancer: Immunological Aspects. Influence on Prognosis and Treatment

   • Israel Davidsohn, Stanislav Kovarik, Rudolf Stejskal

   Pages 105-121

10. Diagnosis of Ovarian Carcinoma by Cul-de-sac Aspiration

    • Ruth M. Graham

    Pages 122-133

11. Cancer Cells in the Blood: Incidence and Importance to Prognosis and Treatment

    • Stuart S. Roberts, Elizabeth E. McGrew, Jonas Valaitis, Warren H. Cole

    Pages 134-145

12. Clinical Staging in Ovarian Carcinoma

    • H. L. Kottmeier

    Pages 146-156

13. Surgical Management — Conservative Surgery

    • H. L. Kottmeier

    Pages 157-164

14. Intestinal Surgery for Advanced Cancer of the Ovary

    • Alexander Brunschwig, Don G. C. Clark

    Pages 165-171

15. Seropapillary and Endometrioid Carcinoma of the Ovary: Survival Rate after Surgery and Radiotherapy

    • Maurice Lenz

    Pages 172-186

16. Megavoltage Irradiation in the Management of Malignant Ovarian Tumours

    • Luis Delclos

    Pages 187-197

17. Intraperitoneal Colloidal Radiogold 198Au Therapy in Ovarian Cancer

    • J. H. Muller

    Pages 198-216

18. Intracavitary Chemotherapy in Ovarian Carcinoma

    • G. Brulé

    Pages 217-225

19. Chemotherapy in Ovarian Cancer

    • Felix Rutledge, Beaury Burns Jr.

    Pages 226-238

20. Systemic Chemotherapy in the Treatment of Ovarian Cancer

    • L. A. Novikova

    Pages 239-245

The incidence of ovarian cancer has progressively increased during the past decade, and its mortality rate has followed a similar course. Conversely, in cancer of the uterine cervix, the mortality rate has diminished. Detection and early diag­ nosis have been the two responsible factors in achieving the decrease in the number of deaths occurring in cancer of the cervix. The revers~ is true in cancer of the ovary: diagnosis as a rule is only established late, when dissemination has already occurred, thus making the control of the disease much more difficult. Clinical staging thus far has not been in use at many centers, and it therefore becomes very difficult to compare results of treatment since we do not know the exact anatomical extent of the disease. Histopathological classification in cancer of the ovary is still a very controversial subject and a uniform terminology is urgently required. Management of patients with cancer of the ovary varies widely from one institu­ tion to another. There is no agreement as to how to treat an ovarian neoplasm; by surgery alone, or, by using radiation and chemotherapy as a complement to the operative treatment. In an effort to shed more light on these items, the Patient Care Committee of the UIce held this symposium, which was unique in the broadness of its scope pertaining to every phase of ovarian cancer.

• Staging
• classification
• diagnosis
• surgery
• therapy

• Clinical Research on Radiotherapy and Chemotherapy, Cancer Institute, Hospital A. C. Camargo, São Paulo, Brasil

  Fernando Gentil, Antonio C. Junqueira

• Department of Pharmacology, São Paulo Medical School, São Paulo, Brasil

  Antonio C. Junqueira

Policies and ethics